Shree Lokanath Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.60 M
- Paid Up Capital ₹ 4.57 M
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.80 M
- Satisfied Charges ₹ 0.40 M
- Revenue Growth -14.48%
- Profit Growth -53.38%
- Ebitda -184.06%
- Net Worth 2.47%
- Total Assets -17.07%
About Shree Lokanath Pharmaceuticals
Shree Lokanath Pharmaceuticals Private Limited (SLPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 June 1996 and has a history of 28 years and seven months. Its registered office is in Aurangabad, Maharashtra.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.60 M and a paid-up capital of Rs 4.57 M.
The company currently has active open charges totaling ₹0.80 M. The company has closed loans amounting to ₹0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Parikshit Deshpande and Arti Deshpande serve as directors at the Company.
Company Details
- LocationAurangabad, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24233MH1996PTC162323
- Company No.
162323
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Shree Lokanath Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parikshit Deshpande  | Director | 28-Apr-2008 | Current |
| Arti Deshpande | Director | 10-Jun-2004 | Current |
Financial Performance of Shree Lokanath Pharmaceuticals.
Shree Lokanath Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 14.48% decrease. The company also saw a substantial fall in profitability, with a 53.38% decrease in profit. The company's net worth moved up by a moderate rise of 2.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Lokanath Pharmaceuticals?
In 2020, Shree Lokanath Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Niranjan Credit Consultant Private LimitedParikshit Deshpande and Arti Deshpande are mutual person
Charges (Loans)
₹0.80 M
₹0.40 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Feb 2018 | State Bank Of India | ₹0.80 M | Open |
| 10 Mar 1999 | Andhra Bank | ₹0.40 M | Satisfied |
How Many Employees Work at Shree Lokanath Pharmaceuticals?
Unlock and access historical data on people associated with Shree Lokanath Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Lokanath Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Lokanath Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.